Increasing the use of animal-free recombinant antibodies.

Clicks: 231
ID: 79313
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Antibodies are used in a range of research, diagnostic, and regulatory applications. Traditional methods for producing such reagents involve the immunization of animals, which introduces variability into the methods that use them and is not aligned with efforts to replace and reduce animal use. Experts from academia, biotechnology, government, and animal protection organizations met December 3, 2020, at the National Institutes of Health in Bethesda, MD, USA to discuss the status of development and use of animal-free recombinant antibodies and their potential to replace antibodies derived from animals. This paper summarizes the discussion and the actions that resulted to facilitate increased production and use of animal-free recombinant antibodies.
Reference Key
groff2020increasingaltex Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Groff, Katherine;Allen, David;Casey, Warren;Clippinger, Amy;
Journal altex
Year 2020
DOI
10.14573/altex.2001071
URL
Keywords
surveillance cameroon health facility global health security event-based surveillance early warning and response

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.